# Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia

> **NCT04588857** · PHASE4 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 60 (estimated)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04588857
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04588857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04588857, "Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04588857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*